(Q39486739)
Statements
Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml (English)
M Sjöberg
P Nitescu
L Appelgren
1 February 1994
scientific article
No description defined